课题基金 / 基金详情

Multi-gene Subunit Vaccine Platform Against Y. pestis

Multi-gene Subunit Vaccine Platform Against Y. pestis
鼠疫耶尔森多基因亚单位疫苗平台
批准号:
7455420
负责人:
Shan Lu
金额:
$40.26万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-15 至 2012-08-31

项目摘要

项目成果

Shan Lu的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):本申请的总体目标是开发改进的鼠疫疫苗。我们的建议是基于我们最近在鼠疫疫苗研究方面的进展,其中包括:1)使用DNA免疫方法寻找额外的保护性抗原;2)发现细胞介导的免疫反应在保护鼠疫杆菌感染方面的作用。对当前提案的支持将使我们能够开发一个独特的技术平台,该平台可以将抗原发现、疫苗配方优化和基于亚基的多基因鼠疫疫苗的有效无针皮内递送结合到一个系统中。
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this application is to develop improved plague vaccines. Our proposal was developed based on our recent progress in plague vaccine studies which includes 1.) the use of a DNA immunization approach to search for additional protective antigens and 2.) the discovery of cell mediated immune responses in the protection of Y. pestis infection. Support for the current proposal will allow us to develop a unique technological platform which can combine antigen discovery, optimization of vaccine formulation, and efficient needle free intradermal delivery of subunit-based multi-gene plague vaccines into one system. Specific Aim 1: To continue our work using DNA immunization as a tool to screen for additional protective antigens against plague, including both the study of individual candidate antigens and the high throughput screening of animal sera which has been immunized with specialized Y. pestis strains deficient for the dominant antigens LcrV and F1. This approach exploits the availability of a newly constructed Y. pestis expression library and protein microarray techniques. Specific Aim 2: To study the cellular immunological mechanisms that are important for improving the protective efficacy of plague vaccines which includes the use of the DNA prime plus protein boost approach to increase the level and longevity of protective antibody responses induced by subunit plague vaccines. Specific Aim 3: To conduct late-phase preclinical immunogenicity and protection studies in non-human primates to prepare for a clinical study with optimized plague vaccine formulation and DNA delivery device that has been proven effective in humans. Plain, lay language summary: This study is designed to produce effective biodefense vaccines against Y. pestis, the highly lethal bacteria that causes plague, an infection that has the potential to cause a high percentage of human fatalities. This study is part of the broad biodefense effort to protect against such agents if they were to be used for bioterrorism purposes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing the immunogenicity of next generation polyvalent HIV vaccine formulati
Optimization of HIV vaccines for the induction of cross-reactive antibodies
Optimization of HIV vaccines for the induction of cross-reactive antibodies
Optimization of HIV vaccines for the induction of cross-reactive antibodies
海外基金